CorMedix Inc. (CRMD) vs Fulgent Genetics, Inc. (FLGT)
A side-by-side comparison of CorMedix Inc. and Fulgent Genetics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRMD
CorMedix Inc.
$7.22HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
FLGT
Fulgent Genetics, Inc.
$20.72HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Total return — CRMD vs FLGT
growth of $100 · dividends reinvested · last 10yCRMD -48.3% (-6.4%/yr)FLGT +130.1% (+8.7%/yr)FLGT compounded faster over this window
CRMD FLGT
CRMD vs FLGT: by the numbers
- •FLGT is the larger company ($588M vs $566M market cap).
- •CRMD is profitable (40.49% net margin) while FLGT runs a net loss (-26.05%).
- •CRMD grew revenue faster over the past five years (352.03% vs -18.66% CAGR).
Metrics side by side
Valuation
| Metric | CRMD | FLGT |
|---|---|---|
| P/E ratio | 3.39 | N/A |
| Forward P/E | 14.59 | N/A |
| P/S ratio | 1.23 | 1.82 |
| P/B ratio | 1.23 | 0.59 |
| EV / EBITDA | 1.80 | N/A |
| FCF yield | 44.18% | N/A |
Profitability
| Metric | CRMD | FLGT |
|---|---|---|
| Gross margin | 82.78% | 35.58% |
| Operating margin | 46.95% | -28.23% |
| Net margin | 40.49% | -26.05% |
| ROE | 40.62% | -8.42% |
| ROIC | 27.87% | -11.80% |
Growth (annualized)
| Metric | CRMD | FLGT |
|---|---|---|
| Revenue CAGR (5Y) | 352.03% | -18.66% |
| Total return CAGR (5Y) | 9.70% | -22.38% |
Frequently asked
- Which has grown faster, CRMD or FLGT?
- Over the past five years, CRMD grew revenue faster — CRMD at a 352.03% CAGR versus FLGT at -18.66%.
- Is CRMD or FLGT more profitable?
- CRMD runs the higher net margin — CRMD at 40.49% versus FLGT at -26.05%.
- How have CRMD and FLGT total returns compared?
- Over the past 10 years, CRMD delivered -7.74% and FLGT delivered 8.90% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
CorMedix P/E ratioCorMedix ROEFulgent Genetics ROECorMedix operating marginFulgent Genetics operating marginCorMedix revenue growthFulgent Genetics revenue growthCorMedix free cash flowFulgent Genetics free cash flow
CorMedix & Fulgent Genetics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.